Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Assessing tumor vascularization as a potential biomarker of imatinib resistance in gastrointestinal stromal tumors by dynamic contrast-enhanced magnetic resonance imaging
Authors
Keywords
Gastrointestinal stromal tumor, Angiogenesis, DCE-MRI, Imatinib, Gadolinium contrast agent
Journal
Gastric Cancer
Volume 20, Issue 4, Pages 629-639
Publisher
Springer Nature
Online
2016-12-20
DOI
10.1007/s10120-016-0672-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gd-AAZTA-MADEC, an improved blood pool agent for DCE-MRI studies on mice on 1 T scanners
- (2016) Dario Livio Longo et al. BIOMATERIALS
- Functional imaging of the angiogenic switch in a transgenic mouse model of human breast cancer by dynamic contrast enhanced magnetic resonance imaging
- (2016) Lorena Consolino et al. INTERNATIONAL JOURNAL OF CANCER
- CCR 20th Anniversary Commentary: A Genetic Mechanism of Imatinib Resistance in Gastrointestinal Stromal Tumor--Where Are We a Decade Later?
- (2015) C. R. Antonescu et al. CLINICAL CANCER RESEARCH
- Cluster analysis of quantitative parametric maps from DCE-MRI: application in evaluating heterogeneity of tumor response to antiangiogenic treatment
- (2015) Dario Livio Longo et al. MAGNETIC RESONANCE IMAGING
- Prognostic value of DCE-MRI in breast cancer patients undergoing neoadjuvant chemotherapy: a comparison with traditional survival indicators
- (2014) Martin D. Pickles et al. EUROPEAN RADIOLOGY
- Contrast-enhanced endoscopic ultrasonography can predict a higher malignant potential of gastrointestinal stromal tumors by visualizing large newly formed vessels
- (2014) Yasunobu Yamashita et al. JOURNAL OF CLINICAL ULTRASOUND
- DCE-MRI in hepatocellular carcinoma-clinical and therapeutic image biomarker
- (2014) Bang-Bin Chen WORLD JOURNAL OF GASTROENTEROLOGY
- CT-based response assessment of advanced gastrointestinal stromal tumor: Dual energy CT provides a more predictive imaging biomarker of clinical benefit than RECIST or Choi criteria
- (2013) M. Meyer et al. EUROPEAN JOURNAL OF RADIOLOGY
- MRI of cells and mice at 1 and 7 Tesla with Gd-targeting agents: when the low field is better!
- (2011) Simonetta Geninatti-Crich et al. Contrast Media & Molecular Imaging
- Relaxometric Study of a Series of Monoaqua GdIII Complexes of Rigidified EGTA-Like Chelators and Their Noncovalent Interaction with Human Serum Albumin
- (2011) Mauro Botta et al. EUROPEAN JOURNAL OF INORGANIC CHEMISTRY
- Gastrointestinal Stromal Tumors: Disease and Treatment Update
- (2011) Maria Y. Ho et al. GASTROENTEROLOGY
- Contrast-Enhanced Dual-Energy CT of Gastrointestinal Stromal Tumors
- (2011) Paul Apfaltrer et al. INVESTIGATIVE RADIOLOGY
- Histopathology of gastrointestinal stromal tumor
- (2011) Markku Miettinen et al. JOURNAL OF SURGICAL ONCOLOGY
- The Heat Shock Protein 90 Inhibitor IPI-504 Induces KIT Degradation, Tumor Shrinkage, and Cell Proliferation Arrest in Xenograft Models of Gastrointestinal Stromal Tumors
- (2011) G. Floris et al. MOLECULAR CANCER THERAPEUTICS
- Visualizing vascular permeability and lymphatic drainage using labeled serum albumin
- (2010) Katrien Vandoorne et al. ANGIOGENESIS
- Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements
- (2010) Gunnar Brix et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Imaging of Tumor Angiogenesis: Functional or Targeted?
- (2009) Baris Turkbey et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Perfusion patterns of metastatic gastrointestinal stromal tumor lesions under specific molecular therapy
- (2009) Marcus Schlemmer et al. EUROPEAN JOURNAL OF RADIOLOGY
- Risk stratification of patients diagnosed with gastrointestinal stromal tumor
- (2008) Heikki Joensuu HUMAN PATHOLOGY
- Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
- (2008) Michael C. Heinrich et al. JOURNAL OF CLINICAL ONCOLOGY
- Gastrointestinal stromal tumors and leiomyosarcomas
- (2008) Steven C. Katz et al. JOURNAL OF SURGICAL ONCOLOGY
- Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation
- (2008) Tuomas Tammela et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started